(Q50114310)

25 February 2018

title

Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly. (English)

1 reference

25 February 2018

1 reference

1 reference

3

Blaise Genton

1 reference

25 February 2018

Valérie D'Acremont

1

1 reference

25 February 2018

Christian Herzog

series ordinal

2

1 reference

25 February 2018

publication date

1 March 2006

1 reference

25 February 2018

Journal of Travel Medicine

published in

1 reference

25 February 2018

volume

13

1 reference

25 February 2018

issue

2

1 reference

25 February 2018

page(s)

78-83

1 reference

25 February 2018

Epidemiology and prevention of hepatitis A in travelers

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Travel health knowledge, attitudes and practices among United States travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Travel vaccines and elderly persons: review of vaccines available in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Immunogenicity of combined hepatitis A and B vaccine in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Immunogenicity of Twinrix in older adults: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Successful Booster Antibody Response up to 54 Months after Single Primary Vaccination with Virosome-Formulated, Aluminum-Free Hepatitis A Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Hepatitis A booster vaccination: is there a need?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Efficacy of Virosome Hepatitis A Vaccine in Young Children in Nicaragua: Randomized Placebo‐Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.2006.00001.X

10.1111/J.1708-8305.2006.00001.X

21 January 2018

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018